MATRIX METALLOPROTEINASES AS PATHOGENETIC AND DIAGNOSTIC BIOMARKERS FOR SKIN SCARS
Issue:
3
Year:
2017
To develop optimal treatments for skin scarring changes, it is necessary to understand the pathogenesis of the wound process that is a complex set of biological reactions.
Keywords:
dermatology
scarring tissue
biomarkers
matrix metalloproteinases
References:
- Sten'ko A.G., Kruglova L.S., Shmatova A.A. i dr. Konservativnoe lechenie formirujuschihsja rubtsov: obzor sovremennyh tehnologij // Vestnik esteticheskoj meditsiny. – 2014; 13 (2): 42–50.
- Tarasenkova M.S., Jutskovskaja Ja.A., Naumchik G.A. i dr. Sovremennye tsmetody profilaktiki postoperatsionnyh patologicheskih rubtsov kozhi // Eksperim. i klin. dermatokosmetol. – 2010; 3: 50–4.
- Roh Y., Seo C., Jang K. Effects of a skin rehabilitation nursing program on skin status, depression, and burn-specific health in burn survivors // Rehabil. Nurs. – 2010; 35 (2): 65–9.
- Mamalis A., Jagdeo J. Light-emitting diode-generated red light inhibits keloid fibroblast proliferation // Dermatol. Surg. – 2015; 41 (1): 35–9.
- Wang A., Zhang W., Liang F. et al. Pre-expanded thoracodorsal artery perforator-based flaps for repair of severe scarring in cervicofacial regions // J. Reconstr. Microsurg. – 2014; 30 (8): 539–46.
- Gill S., Parks W. Metalloproteinases and their inhibitors: regulators of wound healing // Int. J. Biochem. Cell Biol. – 2008; 40: 1334–47.
- Gershtejn E.S., Levkina N.V., Digaeva M.A. i dr. Matriksnye metalloproteinazy-2, -7, -9 i tkanevoj ingibitor metalloproteinaz 1-go tipa v opuholjah i syvorotke krovi bol'nyh s novoobrazovanijami jaichnikov // Bjul. eksperim. biol. i meditsiny. – 2010; 149 (5): 562–5.
- Nissi R., Talvensaari-Mattila A., Kotila V. et al. Circulating matrix metalloproteinase MMP-9 and MMP-2/TIMP-2 complex are associated with spontaneous early pregnancy failure // Reprod. Biol. Endocrinol. – 2013; 15 (11): 2
- Cho S., Ryu D., Lee S. et al Scar characteristics and treatment expectations: a survey of 589 patients // Cosmet. Laser Ther. – 2009; 11 (4): 224–8.
- Wagner W., Alfrink M., Micke O. Results of prophylactic irradiation in patients with resected keloids a retrospective analysis // Acta. Oncol. – 2000; 39 (2): 217–20.
- Margolina A.A., Ernandes E.I., Zajkina O.E. Novaja kosmetologija / M.: Kosmetika i meditsina, 2002; 208 s.
- Matytsin V.O., Miheeva N.V. Metody instrumental'noj diagnostiki i funktsional'nogo sostojanija kozhi // Natural'naja farmakol. i kosmetol. – 2005; 2: 35–7.
- Snarskaja E.S. Kompleksnaja terapija esteticheskih defektov kozhi v rezul'tate patologicheskogo fibrogeneza // Dermatologija. Prilozhenie k zhurnalu Consilium Medicum. – 2013; 2–3: 15–20.
- Artykov K.P., Saidov M.S., Muhamadieva K.M. Vlijanie immunomodulirujuschej terapii na rezul'taty hirurgicheskoj korrektsii kelloidnyh rubtsov kozhi // Doklady Akademii nauk Respubliki Tadzhikistan. – 2014; 57 (2): 164–9.
- Chen J., Wang J., Zhuang H. Influence of substance P on the proliferation and apoptosis of fibroblasts of pathological scars // Zhonghua Shao Shang ZaZhi. – 2006; 22 (4): 277–80.
- Sauder D.N. Cutaneous immunobiology // Ann. Dermatol. Venereol. – 2002; 129: 274–83.
- Wolfram D., Tzankov A., Polzl P. et al. Hypertrophic scars and keloids. A review of their pathophysiology, risk factors, and therapeutic management // Dermatol. Surg. – 2009; 35: 171–81.
- Eto H., Suga H., Aoi N. et al. Therapeutic potential of fibroblast growth factor-2 for hypertrophic scars: upregulation of MMP-1 and HGF expression // Lab. Invest. – 2012; 92: 214–23.
- Katunina A.I., Gershtejn E.S., Tereshkina I.V. i dr. Matriksnye metalloproteinazy v opuholjah bol'nyh rakom molochnoj zhelezy // Klin. lab. diagnostika. – 2010; 9: 27–7a.
- Ortak H., Demir S., Ateş Ö. et al. The role of MMP2 (–1306C>T) and TIMP2(–418G>C) promoter variants in age-related macular degeneration // Ophthalmic Genet. – 2013; 34 (4): 217–22.
- Imaizumi R., Akasaka Y., Inomata N. et al. Promoted activation of matrix metalloproteinase (MMP)-2 in keloid fibroblasts and increased expression of MMP-2 in collagen bundle regions: implications for mechanisms of keloid progression // Histopathology. – 2009; 54: 722–30.
- Tandara A., Mustoe T. MMP- and TIMP-secretion by human cutaneous keratinocytes and fibroblasts – impact of coculture and hydration // J. Plast. Reconstr. Aesthet. Surg. – 2011; 64: 108–16.
- Ulrich D., Ulrich F., Unglaub F. et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with different types of scars and keloids // J. Plast. Reconstr. Aesthet. Surg. – 2010; 63: 1015–21.
- Simon F., Bergeron D., Larochelle S. et al. Enhanced secretion of TIMP-1 by human hypertrophic scar keratinocytes could contribute to fibrosis // Burns. – 2012; 38: 421–7.
- Taghiabadi E., Mohammadi P., Aghdami N. et al. Treatment of Hypertrophic Scar in Human with Autologous Transplantation of Cultured Keratinocytes and Fibroblasts along with Fibrin Glue // Cell J. – 2015; 17 (1): 49–58.
- Sadick H., Herberger A., Riedel K. et al. TGF-beta1 antisense therapy modulates expression of matrix metalloproteinases in keloid-derived fibroblasts // Int. J. Mol. Med. – 2008; 22: 55–60.
- Fujiwara M., Muragaki Y., Ooshima A. Keloid-derived fibroblasts show increased secretion of factors involved in collagen turnover and depend on matrix metalloproteinase for migration // Br. J. Dermatol. – 2005; 153: 295–300.
- Uchida G., Yoshimura K., Kitano Y. et al. Tretinoin reverses upregulation of matrix metalloproteinase-13 in human keloid derived fibroblasts // Exp. Dermatol. – 2003; 12 (Suppl. 2): 35–42.
- Chavez-Munoz C., Hartwell R., Jalili R. et al. Application of an indoleamine 2,3-dioxygenase-expressing skin substitute improves scar formation in a fibrotic animal model // J. Invest. Dermatol. – 2012; 132: 1501–5.
- Li Y., Kilani R., Rahmani-Neishaboor E. et al. Kynurenine increases matrix metalloproteinase-1 and -3 expression in cultured dermal fibroblasts and improves scarring in vivo // J. Invest. Dermatol. – 2014; 134: 643–50.
- Wei Y., Yan X., Ma L. et al. Oleanolic acid inhibits hypertrophic scarring in the rabbit ear model // Clin. Exp. Dermatol. – 2011; 36: 528–33.
- Kuo Y., Wu W., Jeng S. et al. Suppressed TGF-beta1 expression is correlated with up-regulation of matrix metalloproteinase-13 in keloid regression after flashlamp pulsed-dye laser treatment // Lasers Surg. Med. – 2005; 36: 38–42.
- Rahmani-Neishaboor E., Yau F., Jalili R. et al. Improvement of hypertrophic scarring by using topical anti-fibrogenic/anti-inflammatory factors in a rabbit ear model // Wound Repair Regen. – 2010; 18: 401–8.
- Djafarzadeh R., Conrad C., Notohamiprodjo S. et al. Cell surface engineering using glycosylphosphatidylinositol anchored tissue inhibitor of matrix metalloproteinase-1 stimulates cutaneous wound healing // Wound Repair Regen. – 2014; 22: 70–6.
- Stuart K., Paderi J., Snyder P. et al. Collagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarring // PLoS One. – 2011; 6: e22139.
- Ghahary A., Karimi-Busheri F., Marcoux Y. et al. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts // J. Invest. Dermatol. – 2004; 122: 1188–97.
- Rahmani-Neishaboor E., Jackson J., Burt H. et al. Composite hydrogel formulations of stratifin to control MMP-1 expression in dermal fibroblasts // Pharm. Res. – 2009; 26: 002–2014.
- Lee W., Ahn H., Roh H. et al. Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids // Exp. Dermatol. – 2015; 24 (8): 591–7.